Ipramol Steri-Neb (Ipratropium Bromide, Salbutamol)

Ipratropium bromide blocks muscarinic receptors in the airway, preventing acetylcholine‑induced constriction, while salbutamol activates β2‑adrenergic receptors, causing smooth‑muscle relaxation. The combined action results in additive bronchodilation, opening the airways more effectively than either agent alone.

The dose of Ipramol Steri‑Neb is determined by the prescribing clinician based on the severity of the patient’s condition, response to therapy, and specific inhalation device. Typical regimens involve one to two inhalations per dose, but the exact schedule must follow the prescriber’s order.

Safety data for ipratropium bromide and salbutamol during pregnancy and lactation are limited. The medication should be used only if the potential benefit justifies any potential risk to the fetus or infant. Patients should discuss use with their healthcare provider before starting therapy.

To order Ipramol Steri‑Neb, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and import documentation.

Compared with single‑agent bronchodilators, the ipratropium‑salbutamol combination offers additive bronchodilation by targeting both cholinergic and β2 pathways. This can result in faster and more sustained relief of bronchospasm than using salbutamol or ipratropium alone, especially in patients with severe or refractory symptoms.

Ipramol Steri‑Neb should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct light, and ensure the container is tightly closed when not in use.

The medication is delivered via inhalation using a nebulizer or metered‑dose inhaler, as directed by a healthcare professional. The patient inhales the aerosolized dose, allowing the drug to reach the lower airways where it exerts its bronchodilating effect.

Serious adverse reactions, although rare, include paradoxical bronchospasm, angioedema, and severe allergic responses such as anaphylaxis. If any of these occur, immediate medical attention is required.

Patients with a known hypersensitivity to ipratropium bromide, salbutamol, or any component of the formulation should avoid using Ipramol Steri‑Neb. Caution is also advised for individuals with certain cardiac arrhythmias, uncontrolled hypertension, or severe glaucoma, and they should consult their physician before use.